UPDATED Jul 10, 2025
Discover Norwegian Pharmaceuticals & Biotech Growth Stocks that are on the OSEAX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ABS | NOK 3.57 | -4.8% | -65.7% | NOK 99.4m | n/a | PS2.2x | E97.1% | n/a | ||
NAVA | NOK 22.30 | -0.4% | -32.6% | NOK 386.8m | NOK 34.00 | PB1.8x | E90.4% | n/a | ||
PHO | NOK 56.10 | -2.4% | -3.9% | NOK 1.5b | NOK 82.50 | PE698.1x | E89.1% | 0% | ||
AZT | NOK 16.90 | -0.6% | -26.8% | NOK 842.7m | NOK 17.50 | PE393.8x | E77.2% | n/a | ||
BGBIO | NOK 1.22 | -8.6% | -90.0% | NOK 47.7m | NOK 1.90 | PS56x | E12.9% | n/a | ||
NYKD | NOK 1.74 | -6.2% | -87.9% | NOK 585.8m | NOK 6.75 | PS6.8x | E1.1% | 55.7% | ||
ZLNA | NOK 13.55 | -4.3% | n/a | NOK 276.2m | n/a | PS5229.3x | E-26.3% | n/a | ||
EXTX | NOK 2.96 | 5.7% | -62.8% | NOK 187.3m | n/a | PB1.6x | n/a | n/a | ||
VISTN | NOK 24.00 | -1.2% | 12.1% | NOK 1.1b | n/a | PE13.9x | n/a | 5.2% | ||
CRNA | NOK 0.64 | 1.3% | -73.5% | NOK 66.9m | NOK 1.00 | PE1.2x | n/a | n/a | ||
NORD | NOK 80.00 | 0% | n/a | NOK 410.5m | n/a | PE3.3x | n/a | 0% | ||
ONCIN | NOK 1.60 | -6.0% | n/a | NOK 148.6m | n/a | PS19.3x | n/a | n/a | ||
SOFTX | NOK 0.11 | -5.3% | 6.5% | NOK 239.7m | n/a | PS25.6x | n/a | n/a | ||
PCIB | NOK 1.61 | -2.4% | -10.7% | NOK 61.0m | n/a | PS8.9x | n/a | n/a | ||
LYTIX | NOK 9.00 | 1.1% | -7.2% | NOK 606.2m | NOK 13.00 | PS1010.5x | S39.7% | n/a | ||
HBC | NOK 1.75 | -5.4% | -13.6% | NOK 715.3m | n/a | PS2.6x | n/a | n/a | ||
TRMED | NOK 2.48 | -1.2% | 139.4% | NOK 862.0m | n/a | PB2.6x | n/a | n/a |